Tissue microarrays (TMAs) are high-throughput diagnostic technologies used for simultaneous proteins expression analysis in multiple tissue samples on a single slide. Tissue microarrays consists of small-tissue cores embedded in paraffin blocks in an array pattern. The global tissue microarray market is anticipated to generate a CAGR of 10.88% during the forecast period of 2017 to 2023.
Market Dynamics:
Drivers
Quick, cost-effective technique, efficient tool for high-throughput molecular analysis of tissues, less labor-intensive and requiring lesser number of steps are the operational and economic driving factors of the market. Rising incidence and prevalence of diseases such as cancer, infectious diseases etc., growing screening, and growing demand from end users such as diagnostic labs are driving the market. According to the 2017 estimates of the American Cancer Society, approximately 12% of the U.S. women develop breast cancer with an estimated 252,710 new cases in 2017.
The growing research and development in drug discovery and infectious diseases are also important drivers of the market as it results in demand for well-characterized human tissues samples and techniques. Thus tissue microarray is substituting the traditional slide-by-slide tissue analysis technique which needed larger samples and was also time consuming, and expensive.
Technical advantages such as antigen longevity, tissue conservation, tissue retention, low requirements of reagents and others are also resulting in faster market adoption.
Get a sample report at https://www.marketresearchfuture.com/sample_request/1213 .
Restraints
Technical constraints such as lower tissue yield due to differentiation in donor block thickness, poor results of heterogeneous tumors and others are restraints on the market.
Segmentation:
The global tissue microarray market is divided on the basis of procedure, technology, application, and end user and regions so as to gain more meaningful conclusions of the market potential.
Procedure – immunohistochemistry, fluorescent in-situ hybridization, and frozen tissue array.
Technology – DNA microarray, polymerase chain reaction, next-generation sequencing, northern blotting, and western blotting.
Application – oncology, gene expression profiling, SNP detection, double-stranded B-DNA microarrays, and comparative genomic hybridization, and sequencing bioinformatics.
End user – pharmaceutical and biotechnological companies, research organization, and others.
Regions – Americas, Europe, Asia Pacific and Middle East & Africa
Browse Complete report at https://www.marketresearchfuture.com/reports/tissue-microarray-market-1213 .
Regional Analysis:
The Americas dominates the global tissue microarray market owing to large incomes, excellent healthcare infrastructure, large research and development base. The U.S. market has also got a boost from the compulsory screening program of newborns under the affordable healthcare act.
Europe led by Germany, France and others account for the second position in the market. The large healthcare spending of European nations also drive the market. Organization for Economic Co-operation and Development (OECD), reveals that the share of GDP to health spending in Germany was 11.0 % in 2013.
Asia Pacific is expected to be the fastest growing market owing to developing economies in nations such as China, India and others.
The Middle East & Africa is expected to generate moderate growth due to poor healthcare infrastructure and economy. The gulf economies of Saudi Arabia, Qatar and Kuwait are expected to account for largest fraction of the Middle East & Africa market for tissue microarray.
Prominent Players:
Some of the prominent players are Merck Sharp & Dohme Corp, Applied Microarrays, Phalanx Biotech, Agilent Technologies, Arrayit, Illumina, Inc., general electric, Perkin Elmer, Asterand Bioscience, Qiagen, Takara Bio, Protein Biotechnologies Inc., Pantomics Inc., and others.
More Inquire at https://www.marketresearchfuture.com/enquiry/1213 .
Industry News:
June, 2017 – Philips launched web-based image and data management platform Xplore, intended to help pharma and academic researchers. Xplore provides multi-source data integration and also allows storing of clinical, image analysis, molecular and genomic data, promotes multi-site collaboration, data mining, search capabilities tools, knowledge sharing and others.
November, 2016 – StatLab launched 3D reference standard tissue microarray controls with benefits such as consistent IHC marker expression profile, high reproducibility and calibration reference standardization adoption.
Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/tissue-microarray-market-1213